Female sex and discontinuation of isoniazid due to adverse effects during the treatment of latent tuberculosis.

Pettit AC, Bethel J, Hirsch-Moverman Y, Colson PW, Sterling TR, Tuberculosis Epidemiologic Studies Consortium
J Infect. 2013 67 (5): 424-32

PMID: 23845828 · PMCID: PMC3788833 · DOI:10.1016/j.jinf.2013.07.015

MeSH Terms (16)

Adult Alcohol Drinking Antitubercular Agents Canada Female Humans Isoniazid Latent Tuberculosis Male Middle Aged Patient Compliance Prospective Studies Regression Analysis Sex Factors Substance-Related Disorders United States

Connections (1)

This publication is referenced by other Labnodes entities: